Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGROTH + Cytrans Granules for periodontal tissue regeneration in severe periodontitis
jRCTs051190045Completed
- Sponsor
- GC Biopharma Corp
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of regorafenib in periodontitis, sponsored by GC Biopharma Corp. Primary endpoint: Adverse events related to REGROTH + Cytrans Granules. Started Aug 2019; status: completed.
02
Drugs
regorafenib
03
Conditions
periodontitis
Beyond the preview
Go deeper on jRCTs051190045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190045.